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INTRODUCTION
Since Pierre Rayer first reported renal vein thrombosis asso-
ciated with nephrotic syndrome in 1837, thrombosis is known
to be one of the main complications of nephrotic syndrome
with the renal vein being the most frequent site (1-5). Also
since Fishberg first drew general attention to the arterial
thrombi in 1954, both venous and arterial thrombosis have
been observed in nephrotic patients. Although arterial throm-
bosis has rarely been reported and is mainly observed in chil-
dren, it is a potentially serious problem in nephrotic patients.
Therefore awareness of its pathogenesis and assessment of
the risk factors for arterial thrombosis are required to allow
appropriate prophylactic management. Up to now, however,
there are no reliable risk factors to suggest anticoagulation
therapy in patients with nephrotic syndrome and prophylac-
tic anticoagulants remains controversial.
We report a case of cerebral infarction in a 53-yr-old man
with nephrotic syndrome with a review of cerebral infarction
in adults associated with nephrotic syndrome in English and
Korean literatures to identify predictive risk factors and to
reveal potential benefits of prophylactic anticoagulants.
CASE REPORT
A 53-yr-old man was hospitalized in April 2002 because
of a sudden motor weakness in his left extremities, dysarthria,
right eye visual disturbance, and headache. A diagnosis of
nephrotic syndrome had been made elsewhere in 3 weeks
before admission, based on clinical manifestation, blood, and
urinary abnormalities and focal segmental glomerulosclero-
sis was confirmed by percutaneous renal biopsy. Also he had
been diagnosed with alcohol-associated liver cirrhosis (Child-
Pugh Classification A) from abdominal ultrasonography and
healthy HBV carrier in 7 months before admission. After
diagnosis of focal segmental glomerulosclerosis, he had been
treated with diuretics, angiotensin converting enzyme (ACE)
inhibitor, prednisolone 1 mg/kg/day, and lamivudine with a
dosage of 100 mg/day for the prevention of flare up of viral
hepatitis. He had no history of hypertension or diabetes. He
had been a 30-pack year smoker and a heavy alcoholic, but
quitted smoking and alcohol several months before. On ad-
mission, his general appearance revealed that he was acutely
ill with bilateral pedal edema. His blood pressure was 120/
80 mmHg, pulse rate 120/min, respiratory rate 24/min, and
body temperature 37℃.Cardic examination showed nor-
mal findings. He had no evidence of systemic thromboem-
bolism, deep vein thrombosis, or cervical bruit. Neurologi-
cal examination revealed drowsy mentality with a left-side
motor weakness, and decreased sensory perception on the left
side. He was also exhibited dysarthria and right eye visual
disturbance. However, the high cortical function was normal.
The initial MR and MR angiography of the brain showed
a recent infarction in the right middle cerebral artery territo-
ry and the head of the caudate nucleus, no blood flow signal
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Cerebral Infarction as a Complication of Nephrotic Syndrome
: A Case Report with a Review of the Literature
Arterial thrombosis is relatively rare compared with venous thrombosis in nephrot-
ic syndrome. However, the assessment of its pathogenesis and risk factors in indi-
vidual patient with nephrotic syndrome is necessary to allow appropriate prophylac-
tic management because it is a potentially serious problem. Hereby, with review of
the literature, we report a case of a 53 yr-old man with cerebral infarction associat-
ed with nephrotic syndrome due to focal segmental glomerulosclerosis during the
course of treatments with diuretics and steroid. It reveals that the hypercoagulable
state in nephrotic syndrome can be associated with cerebral infarction in adults. Pro-
phylactic anticoagulants can be considered to reduce the risk of serious cerebral
infarction in nephrotic patients with risk factors such as severe hypoalbuminemia
and on diuretics or steroid treatment, even in young patients regardless of types of
underlying glomerular diseases.
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intensity in the right internal carotid artery (Fig. 1, 2).
Laboratory data showed leukocytosis (2.49×103/ L) and
hematocrit of 31.9% with hemoglobin of 10.9 g/dL, and pl-
atelet of 230×103/ L. The serum sodium level was 136
mEq/L, potassium 4.1 mEq/L, blood urea nitrogen 33 mg/L,
serum creatinine 1.0 mg/L, and total serum protein 3.3 g/dL
with albumin 1.2 g/dL. Urinalysis revealed 4+ albuminuria
and 24-hr urine protein over 7.8 g/day. The serum cholesterol
level was elevated at 539 mg/dL. The liver function tests, pro-
thrombin time, and activated partial thromboplastin time
were normal. The fibrinogen concentration and antithrom-
bin III level were normal. The concentration of free protein
S was 35.0% (normal 70-140%). Plasminogen and platelet
aggregation test were not performed. The negative HBe Ag,
undetectable HBV DNA, and HBs Ag seroconversion after
lamivudine therapy were demonstrated. The C3 and C4 were
in normal ranges. Anticardiolipin (IgM) was 4.9 MPL unit/
mL (normal <12 MPL unit/mL). After the admission, support-
ive care for the cerebral infarction was initiated and he received
anticoagulation therapy later. Hospital course was unevent-
ful with a mild degree of residual left-side motor weakness at
discharge. Two months after discharge, remission of nephrotic
syndrome occurred on medication with steroid, angiotensin
II receptor blocking agent. At present, 1 yr after discharge,
serum albumin level is 4.6 g/dL with serum cholesterol 158
mg/dL and negative albuminuria on tapered dose of predn-
isolone 7.5 mg every other day (QOD).
DISCUSSION
Thromboembolic complication has been well known as a
clinically important sequelae and its risk is higher in patients
with nephrotic syndrome than in any other condition encoun-
tered in internal medicine (1). Although its accurate patho-
genesis remains unclear, hypercoagulability is regarded as a
major factor for thrombosis in nephrotic patients (1-8).
A disequilibrium between the clotting activator system and
Fig. 1. MR diffusion image (A) shows a hemorrhagic infarction of the right parieto-occipital area, T2 weighted image (B) shows recent infarc-
tion involving the posterior 2/3 portion of the right middle cerebral artery territory and the right head of caudate nucleus.
A B
Fig. 2. MR angiography showing a focal luminal narrowing of the
bifurcation site of the right middle cerebral artery and right anterior
communicating artery and no flow signal intensity in the right inter-
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the inhibitor system may be important in the hypercoagu-
lability of nephrotic syndrome.
The study of Kanfer et al. (5) and Kendall et al. (2) demon-
strated a reduction in the concentration of low molecular
weight coagulation factors (factor IX, XI), probably resulting
from increased urinary loss. This is accompanied by an elevat-
ed level of high molecular procoagulatory cofactors (factor V,
VII, VIII, and X) and the fibrinogen level. It is inversely cor-
related with the depression of serum albumin.
Regulatory proteins of the coagulation cascade are also sub-
ject to alterations in nephrotic syndrome. Kauffmann et al.
reported low plasma antithrombin III levels below 70% of
normal in eight of the nine patients studied and a significant
negative correlation between the antithrombin III concentraion
and the urinary protein excretion. This depletion of antithrom-
bin III has been confirmed and shown to be the result of uri-
nary losses of this low-molecular weight protein (3). How-
ever, high concentrations of antithrombin III have also been
reported (2) as well as high and low levels in other series. Mean-
while, Andrassy et al. noted that only patients with a serum
albumin level below 2.0 g/dL showed low level of antithrom-
bin III, and that thromboembolic complications occurred in
some patients with normal antithrombin III levels (1). Also
antithrombin III concentrations increase in response to admin-
istration of steroids.
The fibrinolytic system is disturbed in nephrotic syndrome.
Plasminogen levels have been generally reported as low because
of urinary losses of protein, while  2-antiplasmin and  2-ma-
croglobulin are increased (5).
Vigano-D’Angelo et al. observed low level of free protein S
in patients with nephrotic syndrome as a result of urinary loss
of low molecular weight free protein S. This precludes forma-
tion of activated protein C-protein S complexes required for
inhibition of thrombin activity resulting in a hypercoagula-
ble state (9).
In patients with nephrotic syndrome, increased adenosine
diphosphate (ADP), collagen-induced platelet aggregation,
and increased spontaneous platelet aggregation were observed.
Platelet dysfunction correlated significantly with the degree
of proteinuria and hypercholesterolemia (5).
Besides the above described reasons in favor of a hyperco-
agulable state in nephrotic syndrome, Ozsolylu et al. found
that steroids raise the concentration of several clotting factors,
principally factor VIII (10). Also Lieberman et al. described
that steroids decreased the fibrinolytic activity by incomplete
breakdown of the thrombus (11). And diuretics would favor
the development of thrombotic complications with their vol-
ume depleting effects leading to hemoconcentration.
Case
Age (yr)/
Sex
Renal
disease
Prior 
treatment
Outcome
Albumin
(g/dL)
Fibrinogen
(mg/dL)
Antithrombin
III
Free
protein S
Area of infarction*
First author
(Reference No.)
1 23/M MCD S Died 0.7 1,440 36% Left middle cerebral Parag et al.
artery territory
� (17)
2 36/M MPGN None Right hemiparesis 2.4 701 Normal 55% Left middle cerebral Marsh et al.
aphagia artery territory (18)
3 34/M MGN None Left hemiparesis 2.7 721 Normal Right middle cerebral Marsh et al.
dysarthria artery territory (18)
4 28/M MGN S Right hemiparesis 1.6 550 65% Light middle cerebral Fuh et al.
artery territory (19)
5 21/M MCD S Right hemiparesis 1.5 Normal 59% Light basal ganglia Fuh et al.
internal capsule (19)
6 37/F MGN None Died 2.6 620 Normal 45% Light middle cerebral Chaturvedi et al.
artery territory (20)
7 39/F MPGN S/D Left hemiparesis 2.0 384 Normal 40% Periventricular area Song et al.
dysarthria of the right frontal lobe (21)
8 51/M 2.0 692 69% Right middle and left Fritz and Braune
cerebral artery territory (22)
9 59/M MGN S Visual disturbance 1.7 Normal Bilateral occipital lobes Ogawa et al.
septic shock (23)
10 35/F IgA S Died 1.1 55% Normal Left temproparietal Lee et al.
area
� (24)
11 42/M MCD S Died 1.5 49% Right middle and Pandian et al.
left cerebral artery (25)
territory
12 53/M FSGS S/D Left hemiparesis 1.2 Normal Normal 35% Right MCA territory Yun et al.
dysarthria caudate nucleus head The present case
Table 1. Summary of adult patients with a cerebral infarction in association with nephrotic syndrome in English literature
*Determined by brain computerized tomographic or magnetic resonance images. 
� Concurrent with femoral arteries. MCD, minimal change disease;
MPGN, membranous proliferative glomerulonephropathy; MGN, membranous glomerulonephropathy; FSGS, focal segmental glomerulosclerosis;
MCA, middle cerebral artery; S/D, steroid/diuretics; M, male; F, female.318 Y.W. Yun, S. Chung, S.-J. You, et al.
Other conditions are considered to be contributing factors
to hypercoagulability in nephrotic syndrome. These include
plasma lipid abnormalities, hypovolemia, hypertension, cir-
culating immune complexes, and susceptibility to infections
(12, 13).
Though adult arterial thrombosis is much less common
than venous thrombosis in patients with nephrotic syndrome,
it is a significant and potentially serious problem due to its
high morbidity and mortality. Despite the seriousness, there
are few reliable predictors of the individual risk. In addition
a propensity for arterial thrombosis may be difficult to demon-
strate in adults because of a high baseline incidence and the
presence of complicating factors (hypertension, smoking, etc).
In any case, up to now, prophylactic anticoagulation is a dif-
ficult problem and remains controversial. Few clinicians would
advocate routine anticoagulation in all nephrotic patients.
Robert et al. reported that the most important predictive
factor for the thrombogenic risk in nephrotic syndrome was
the histologic evidence of membranous nephropathy (14).
Andrassy et al. suggested that anticoagulation therapy should
be administered as long as the patient has a serum albumin
level below 2.0 g/dL (1). Bellomo et al. concluded that nephro-
tic patients with membranous nephropathy should receive
prophylactic anticoagulation (15). In 1994 Sarasin and Schif-
ferli suggested that the benefits of prophylactic administra-
tion of oral anticoagulants outweigh the risks in nephrotic
patients with membranous nephropathy by the Markov-based
decision analysis model (16).
Our experience with a case of cerebral infarction in a 53-yr
old man with nephrotic syndrome reminded us of prophylac-
tic anticoagulation to reduce the risk of serious arterial throm-
bosis and suggested that reliable risk factors should be iden-
tified.
We reviewed cerebral infarction in adults associated with
nephrotic syndrome published by English literature (Table
1). Twelve cases of cerebral infarction in adult nephrotic pa-
tients, including this case, have been reported. Male patients
were predominant (9 men and 3 women). The mean age was
38.1 yr (range: 21 to 59 yr). The underlying renal disease
was membranous nephropathy in three patients, membra-
noproliferative glomerulonephropathy in three, minimal
change disease in three, focal segmental glomerulosclerosis
in one and IgA in one, and unknown in one. Steroids and/or
diuretics were used in 8 of 11 patients. The mean serum albu-
min level was 1.45 g/dL (0.7 to 2.7 g/dL). Nine out of twelve
patients had severe hypoalbuminemia less than 2.1 g/dL. The
serum fibrinogen, antithrombin III, free protein S level in
sequence available in 9 of 12, in 11 of 12, and in 7 of 12 of
the adult nephrotic patients with cerebral infarction, respec-
tively. Increased fibrinogen levels appeared in six patients
and a normal level in three. Six patients showed decreased
antithrombin III and serum free protein S was low in four.
Importantly a review of the literature revealed that serious
complications such as death occurred in 4 of 12 relatively
young patients. Also membranous nephropathy was not pre-
dominant; almost all of the cases showed a serum albumin
below 2.1 g/dL and arterial thrombosis was more common on
steroid and/or diuretics therapy.
In Korean literature, 3 cases of cerebral infarction associ-
ated with nephrotic syndrome in adults have been published.
The mean age was 24.7 yr (range 23 to 27 yr). There were two
patients with minimal change disease, and one with focal
segmental glomerulosclerosis. In all cases, steroids and/or
diuretics were used and serum albumin levels were below
2.0 g/dL (26-28).
In conclusion, if nephrotic patients have risk factors such
as severe hypoalbuminemia and are on diuretics or steroid
treatment, even they are young patients with other types of
nephrotic syndrome besides membranous nephropathy, pro-
phylactic anticoagulants can be considered to reduce the risk
of the serious cerebral infarction. Also, we suggest that reli-
able risk factors should be further assessed and the potential
benefit of prophylactic anticoagulation therapy be examined
by decision analysis in nephrotic patients.
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